- Home
- KALU vs VKTX Comparison
KALU vs VKTX Comparison
Compare KALU & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KALU | VKTX |
|---|---|---|
| Founded | 1946 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.3B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KALU | VKTX |
|---|---|---|
| Price | $187.17 | $38.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $147.33 | $95.86 |
| AVG Volume (30 Days) | 216.8K | ★ 2.5M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.78% | N/A |
| EPS Growth | ★ 135.89 | N/A |
| EPS | ★ 3.71 | N/A |
| Revenue | ★ $1,585,900,000.00 | N/A |
| Revenue This Year | $13.37 | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | $48.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.44 | $22.96 |
| 52 Week High | $195.22 | $43.15 |
Technical Indicators
Market Signals| Indicator | KALU | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 52.97 | 73.64 |
| Support Level | $172.51 | $33.65 |
| Resistance Level | $194.82 | $39.78 |
| Average True Range (ATR) | 8.14 | 1.92 |
| MACD | -1.06 | 1.07 |
| Stochastic Oscillator | 48.03 | 87.55 |
Price Performance
Historical ComparisonAbout KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.